• Profile
Close

The effects of intrapartum synthetic oxytocin on maternal postpartum mood: Findings from a prospective observational study

Archives of Women's Mental Health Oct 13, 2018

Takács L, et al. – Given that the antidepressant and anxiolytic effects of plasma oxytocin are well-documented, researchers investigated the association of synthetic oxytocin (synOT) with maternal mood postpartum using a prospective design. Upon screening 260 women for depressive symptoms in the last trimester of pregnancy and then again 6 weeks and 9 months postpartum using the Edinburgh Postnatal Depression Scale, the investigators noted that synOT predicted a significantly lower risk of postpartum depression (PPD). A history of depression and negative childbirth experience were noted to enhance the risk for PPD. Outcomes indicated that synOT administered intrapartum does not affect maternal mood immediately but may come to effect some weeks following childbirth to protect mothers from developing PPD symptoms.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay